JD Supra

Avelox® Approved for Plague Under Animal Efficacy Rule

On May 8, 2015, FDA approved a new antibacterial treatment for plague, Avelox ® (moxifloxacin). Plague is a deadly infectious disease caused by the enterobacteria Yersinia pestis, which can be spread ...
Healio

FDA approves Avelox for plague

Please provide your email address to receive an email when new articles are posted on . The FDA today announced its approval of moxifloxacin for the prevention and treatment of pneumonic and ...
Medical Xpress

Avelox approved for plague

(HealthDay)—Avelox (moxifloxacin) was approved by the U.S. Food and Drug Administration on Friday to treat plague, a rare but deadly bacterial infection that can strike the lungs (pneumonic), blood ...
EurekAlert!

FDA approves AVELOX (moxifloxacin HCl) for treatment of complicated intra-abdominal infections

Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has approved the once-daily, broad-spectrum antibiotic AVELOX® (moxifloxacin HCl) for a new use ...
Finanznachrichten

FDA Approves Avelox(R) (moxifloxacin HCI) for Community Acquired Pneumonia Due to Multi-Drug Resistant Streptococcus pneumoniae

Avelox demonstrated excellent clinical and bacteriological success against strains resistant to two to five commonly used antibiotics, including macrolides such as clarithromycin and azithromycin, ...
EurekAlert!

AVELOX as effective as multi-dose combination therapy for intra-abdominal infections

Schering-Plough Corporation (NYSE: SGP) today reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as effective and well tolerated as a standard multi ...
Medscape

FDA Safety Labeling Changes: Viread, Advil, Avelox, Cipro, and ChloraPrep One Step

Oct. 13, 2004 -- The U.S. Food and Drug Administration (FDA) approved in July revisions to safety labeling to advise healthcare professionals of the following changes: tenofovir disoproxil fumarate ...
Grand Forks Herald

Health Canada warns antibiotic Avelox may be linked to rare liver problem

TORONTO -- Health Canada is warning that the antibiotic Avelox may be linked to rare but dangerous liver problems. The drug regulator says Bayer Inc., which makes the drug, is updating the product ...
The Financial Express

Lupin receives tentative approval for generic Avelox tablets

It is a fluoroquinolone antibacterial indicated for treating infections in adults Lupin’s US subsidiary, Gavis Pharmaceuticals has received tentative approval for its Moxifloxacin Hydrochloride ...
PharmaTimes

EMEA proposes restrictions on use of Bayer’s Avelox

The European Medicines Agency has recommended restricting the use of antibiotics based on moxifloxacin, marketed by Bayer as Avelox, because of the potential risk of liver damage. The European ...
CBC.ca

Antibiotic Avelox may be linked to rare liver injury

The antibiotic Avelox may be linked to a rare but potentially life-threatening liver injury, Health Canada warns. Avelox, or moxifloxacin, is used to treat a broad spectrum of bacterial infections, ...